insights_auto
Why is PTGX up 3.29%?
Dive Deeperchevron_right
PTGX:NASDAQ
Protagonist Therapeutics Inc
$141.86
arrow_upward
+3.29%(+4.52) 1D
$141.86
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 25, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PTGX...
Open
$141.81
High
$143.45
Low
$138.23
Mkt. cap
9.18B
Avg. vol.
599.11K
Volume
809.29K
P/E ratio
136.78
52-wk high
$160.81
52-wk low
$62.24
EPS
$1.04
Beta
1.80
Shares outstanding
64.71M
No. of employees
141
Open
$141.81
High
$143.45
Low
$138.23
Mkt. cap
9.18B
Avg. vol.
599.11K
Volume
809.29K
P/E ratio
136.78
52-wk high
$160.81
52-wk low
$62.24
EPS
$1.04
Beta
1.80
Shares outstanding
64.71M
No. of employees
141
News stories
From web sources and news partners
MarketBeat
·
1 day ago
Protagonist Therapeutics (NASDAQ:PTGX) Shares Gap Up - What's Next?
News Corp
·
1 day ago
The Peptide Boom That Isn’t About Your Muscles
About Protagonist Therapeutics Inc
CEO-
Employees141
Founded2006
HeadquartersNewark, California, United States
SectorBiotechnology
Websiteprotagonist-inc.com